21世纪全球克罗恩病与溃疡性结肠炎住院趋势:系统综述与时间分析
该系统综述纳入Medline和Embase中报告21世纪炎症性肠病(IBD)、克罗恩病(CD)或溃疡性结肠炎(UC)住院率的人群研究,采用对数线性模型计算平均年度百分比变化(AAPC),并按地区流行病学阶段分层。结果显示,处于患病率复合增长阶段(3期)的国家IBD住院率稳定,而处于发病率加速阶段(2期)的国家住院率快速上升,1期(萌芽期)发展中国家无可用人群研究。
要点
- 3期国家IBD住院率稳定:AAPC -0.13%(95%CI -0.72至0.97)。
- 2期国家IBD住院率快速上升:AAPC 4.44%(95%CI 2.75至6.14)。
- 1期发展中国家无可用人群研究。
核心结论
- 3期国家IBD住院率趋于稳定,而2期新兴工业化国家住院率快速上升,加重全球医疗系统负担。
研究设计与样本
- 系统综述,检索Medline和Embase中报告21世纪IBD、CD或UC住院率的人群研究,采用对数线性模型计算AAPC,随机效应Meta分析合并国家级AAPC,并按地区流行病学阶段分层。
主要发现
- 3期国家IBD住院率稳定:AAPC -0.13%(95%CI -0.72至0.97)。
- 3期国家CD住院率稳定:AAPC 0.20%(95%CI -1.78至2.17)。
- 3期国家UC住院率稳定:AAPC 0.02%(95%CI -0.91至0.94)。
- 2期国家IBD住院率上升:AAPC 4.44%(95%CI 2.75至6.14)。
- 2期国家CD住院率上升:AAPC 8.34%(95%CI 4.38至12.29);2期国家UC住院率上升:AAPC 3.90(95%CI 1.29至6.52)。
局限性
- 1期(萌芽期)发展中国家无可用人群研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The evolving epidemiologic patterns of inflammatory bowel disease (IBD) throughout the world, in conjunction with advances in therapeutic treatments, may influence hospitalization rates of IBD. We performed a systematic review with temporal analysis of hospitalization rates for IBD across the world in the 21st century. METHODS: We systematically reviewed Medline and Embase for population-based studies reporting hospitalization rates for IBD, Crohn's disease (CD), or ulcerative colitis (UC) in the 21st century. Log-linear models were used to calculate the average annual percentage change (AAPC) with associated 95% confidence intervals (95% CIs). Random-effects meta-analysis pooled country-level AAPCs. Data were stratified by the epidemiologic stage of a region: compounding prevalence (stage 3) in North America, Western Europe, and Oceania vs acceleration of incidence (stage 2) in Asia, Eastern Europe, and Latin America vs emergence (stage 1) in developing countries. RESULTS: Hospitalization rates for a primary diagnosis of IBD were stable in countries in stage 3 (AAPC, -0.13%; 95% CI, -0.72 to 0.97), CD (AAPC, 0.20%; 95% CI, -1.78 to 2.17), and UC (AAPC, 0.02%; 95% CI, -0.91 to 0.94). In contrast, hospitalization rates for a primary diagnosis were increasing in countries in stage 2 for IBD (AAPC, 4.44%; 95% CI, 2.75 to 6.14), CD (AAPC, 8.34%; 95% CI, 4.38 to 12.29), and UC (AAPC, 3.90; 95% CI, 1.29 to 6.52). No population-based studies were available for developing regions in stage 1 (emergence). CONCLUSIONS: Hospitalization rates for IBD are stabilizing in countries in stage 3, whereas newly industrialized countries in stage 2 have rapidly increasing hospitalization rates, contributing to an increasing burden on global health care systems.
引用
- Buie MJ, Quan J, Windsor JW, et al. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses. Clin Gastroenterol Hepatol. 2022. PMID: 35863682. doi:10.1016/j.cgh.2022.06.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。